AMRX

AMNEAL PHARMACEUTICALS INC

Healthcare | Mid Cap

$0.24

EPS Forecast

$835.4

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

$0.24

Revenue Forecast:

$835.4

EPS Surprise Forecast:

$0.020

Revenue Surprise Forecast:

$17

Post-release price volatility - High

Post-release Overnight Move:

±7.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

68%

Probability of beating revenue consensus:

81%

Probability of beating both EPS & revs consensus:

59%

Probability of missing both EPS & revs consensus:

11%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

1

Beta (β)

Forward Looking Beta (β):

0.75

Earnings volatility

EPS standard deviation:

$0.11

Revenue standard deviation:

$41

As % of share price:

0.58% VERY HIGH

As % of market cap:

0.65% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.39

Revenue 95th %ile:

$890

EPS 75th %ile:

$0.28

Revenue 75th %ile:

$850

EPS 25th %ile:

$0.21

Revenue 25th %ile:

$823

EPS 5th %ile:

$0.12

Revenue 5th %ile:

$790

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

42% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

37% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$13

Bid-ask per Share:

$0.025